NHS LPP is considering setting up a framework agreement or Dynamic Market for over-labelled medicines used in clinical and out-of-hours settings. Over-labelled medicines are typically used in settings like hospitals, prisons, community health services or prisons where pre-labelled packs improve efficiency and patient safety. Progression and the final structure and scope of the agreement are subject to change following a market needs assessment.

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.